SCHEMBL1142151

SCHEMBL1142151

C=C(C)C(=O)N(COC)COC

nearest known ligand 0.39

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
TSHR P16473 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2120907 0.89 ALDH1A1 (0.34) ALDH1A1
SCHEMBL2122710 0.88 THRB (0.39) ALDH1A1MGAMGAASIMGAM2
SCHEMBL5174250 0.86 CA12 (0.38) ALDH1A1TSHR
SCHEMBL2121311 0.82 TSHR (0.38) ALDH1A1TDP1TSHR
SCHEMBL2121500 0.81 TSHR (0.44) ALDH1A1TSHR
SCHEMBL10598458 0.79 ALDH1A1 (0.37) ALDH1A1TDP1TSHR
SCHEMBL1142673 0.77 THRB (0.44) ALDH1A1MGAMGAASIMGAM2
SCHEMBL7082243 0.77 ALDH1A1 (0.36) ALDH1A1TSHR
SCHEMBL29236265 0.77 ALDH1A1 (0.44) ALDH1A1TDP1TSHR
SCHEMBL11595773 0.75 ALDH1A1 (0.32) ALDH1A1MGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0704722-B1 Color filter, production process thereof, liquid crystal display panel and information processor equipped with the panel CANON KK (JP) 2002-12-18 EP claimed
US-5922401-A INKS CONTAINING A HEAT OR PHOTOCURABLE SUBSTITUTED ACRYLAMIDE HOMO- OR COPOLYMER ARE SEPARATELY APPLIED TO RECESSED PARTS OF APERTURES DEFINED BY BLACK MATRICES ON A BASE BY AN INK JET PRINTING SYSTEM, CURING THE INKS CANON KABUSHIKI KAISHA (JP) 1999-07-13 US claimed
US-5716739-A INK RECEIVING LAYER COMPRISES A HOMO- OR COPOLYMER OF A SUBSTITUTED (METH)ACRYLAMIDE CANON KABUSHIKI KAISHA (JP) 1998-02-10 US claimed
EP-0704722-A2 Color filter, production process thereof, liquid crystal display panel and information processor equipped with the panel CANON KABUSHIKI KAISHA (JP) 1996-04-03 EP claimed
WO-2023047707-A1 PRETREATMENT LIQUID, INK SET, AND PRINTED MATTER 東洋インキSCホールディングス株式会社 2023-03-30 WO disclosed
WO-2022254898-A1 BINDER DISPERSION FOR NON-AQUEOUS SECONDARY BATTERY SEPARATOR, SLURRY COMPOSITION, NON-AQUEOUS SECONDARY BATTERY SEPARATOR, AND NON-AQUEOUS SECONDARY BATTERY 東洋インキSCホールディングス株式会社 2022-12-08 WO disclosed
US-10982118-B2 Release film Oji Holdings Corporation (JP) 2021-04-20 US disclosed
US-20150166812-A1 CURABLE COMPOSITION AND METHOD FOR PRODUCING CURED FILM ASAHI GLASS COMPANY, LIMITED (JP) 2015-06-18 US disclosed
US-20140287200-A1 COMPOUND, POLYMER, CURABLE COMPOSITION, COATING COMPOSITION, ARTICLE HAVING CURED FILM, ARTICLE HAVING PATTERN OF LIQUID-PHILIC REGION AND LIQUID REPELLENT REGION, AND PROCESS FOR PRODUCING IT ASAHI GLASS COMPANY, LIMITED (JP) 2014-09-25 US disclosed
US-8822561-B2 Curable composition and process for producing cured film ASAHI GLASS COMPANY, LIMITED (JP) 2014-09-02 US disclosed
US-20130123382-A1 CURABLE COMPOSITION AND PROCESS FOR PRODUCING CURED FILM ASAHI GLASS COMPANY, LIMITED (JP) 2013-05-16 US disclosed
EP-2586805-A1 CURABLE COMPOSITION AND METHOD FOR PRODUCING CURED FILM Asahi Glass Company, Limited (JP) 2013-05-01 EP disclosed
EP-0982365-A1 EPOXY RESIN COMPOSITION Daiso Co., Ltd. (JP) 2000-03-01 EP disclosed
US-5948577-A Color filter substrate, liquid crystal display device using the same and method of manufacturing color filter substrate CANON KABUSHIKI KAISHA (JP) 1999-09-07 US disclosed
US-5922401-A INKS CONTAINING A HEAT OR PHOTOCURABLE SUBSTITUTED ACRYLAMIDE HOMO- OR COPOLYMER ARE SEPARATELY APPLIED TO RECESSED PARTS OF APERTURES DEFINED BY BLACK MATRICES ON A BASE BY AN INK JET PRINTING SYSTEM, CURING THE INKS CANON KABUSHIKI KAISHA (JP) 1999-07-13 US disclosed
EP-0693507-B1 Curable liquid resin, process for the production thereof, and use thereof TOYO INK MFG CO (JP) 1999-05-19 EP disclosed
US-5716739-A INK RECEIVING LAYER COMPRISES A HOMO- OR COPOLYMER OF A SUBSTITUTED (METH)ACRYLAMIDE CANON KABUSHIKI KAISHA (JP) 1998-02-10 US disclosed
US-5644010-A SOLVENT-FREE TOYO INK MANUFACTURING CO., LTD. (JP) 1997-07-01 US disclosed
EP-0704722-A2 Color filter, production process thereof, liquid crystal display panel and information processor equipped with the panel CANON KABUSHIKI KAISHA (JP) 1996-04-03 EP disclosed
EP-0693507-A2 Curable liquid resin, process for the production thereof, and use thereof TOYO INK MANUFACTURING CO., LTD. (JP) 1996-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140287200-A1 COMPOUND, POLYMER, CURABLE COMPOSITION, COATING COMPOSITION, ARTICLE HAVING CURED FILM, ARTICLE HAVING PATTERN OF LIQUID-PHILIC REGION AND LIQUID REPELLENT REGION, AND PROCESS FOR PRODUCING IT H1-0, DNMT1, BMI1 ALDH1A1 1333/4885MGAM 4629/4885GAA 4883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.